It should come as no surprise that one of the strongest trends in the health care space is the rising wave of natural wellness and natural alternatives categories. While the COVID-19 pandemic may have accelerated the momentum, the movement had begun well before people around the world were sent home, where self-care and well-being became watch words. A natural extension of this focus on self is cannabis, as growing research seems to support the potential benefits this natural plant may provide. Dubbed cannabis 3.0, the next phase of cannabis market maturation features exciting innovation, high-quality offerings and growing investor interest in a space with seemingly unlimted potential. Companies already operating in the space are taking a close look at the opportunities to identify their next best move. BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) (Profile) has chosen to expand and diversify its business, moving from a high-capacity cannabis beverage company into a compelling health and wellness company through a number of accretive acquisitions. Other companies making significant moves in the world of cannabis include Canopy Growth Corporation (NASDAQ: CGC), Tilray Inc. (NASDAQ: TLRY), Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) and Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF).